Evidence map›Paper›PMID 40497976›Full record

ArticleCells2025

Metabolic Reprogramming Triggered by Fluoride in U-87 Glioblastoma Cells: Implications for Tumor Progression?

Wojciech Żwierełło, Agnieszka Maruszewska, Marta Skórka-Majewicz, Agata Wszołek, Izabela Gutowska

Abstract read
In one paragraph

Article in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wojciech ŻwierełłoDepartment of Medical Chemistry, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.ORCID 0000-0001-5987-7120
Agnieszka MaruszewskaInstitute of Biology, University of Szczecin, 71-415 Szczecin, Poland.ORCID 0000-0003-0687-9717
Marta Skórka-MajewiczDepartment of Medical Chemistry, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.
Agata WszołekInstitute of Biology, University of Szczecin, 71-415 Szczecin, Poland.ORCID 0000-0002-2777-874X
Izabela GutowskaDepartment of Medical Chemistry, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.ORCID 0000-0001-8823-0473

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic inflammation is a hallmark of brain tumors, especially gliomas, which exhibit elevated levels of pro-inflammatory mediators within the tumor and its microenvironment. Metabolic disturbances triggered by fluoride as a pro-oxidative agent in glioma cells, known for their high aggressiveness and resistance to therapy-remain poorly understood. Therefore, investigating the impact of physiologically elevated fluoride concentrations on oxidative stress and pro-inflammatory responses in glioma cells represents a relevant and timely research objective.

methodsU-87 human glioblastoma cells were subjected to short-term and long-term exposure to physiologically high concentrations of NaF (0.1-10 µM). Both the cells and the culture medium were analyzed. We assessed levels of reactive oxygen species (ROS), antioxidant defenses, and a panel of cytokines and chemokines.

resultsOur results demonstrated that oxidative stress and inflammatory conditions in U-87 cells varied with fluoride concentration and exposure time. This led to an increase in ROS levels and key pro-inflammatory cytokines, including IL-6 and TNF-α.

conclusionsFluoride compounds can generate ROS and disrupt the antioxidant defense system in U-87 human glioblastoma cells, leading to the initiation and progression of inflammatory states. Furthermore, prolonged exposure to NaF may induce adaptive mechanisms in U-87 cells.

Indexed as

Brain NeoplasmsDisease ProgressionFluoridesGlioblastomaSodium FluorideAntioxidantsCell Line, TumorCytokinesHumansMetabolic ReprogrammingOxidative StressReactive Oxygen SpeciesAntioxidantsCytokinesFluoridesReactive Oxygen SpeciesSodium Fluoridefluoridesgliomasinflammationoxidative stresstumor microenvironment

Identifiers

PMID40497976
PMCPMC12154267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.